Differential expression of galectin-3 in medullary thyroid carcinoma and C-cell hyperplasia

Clinical Endocrinology

Volumn 57, Issue 6, 2002, Pages 813-819

  Faggiano, Antongiulio ^a   Talbot, Monique ^a   Lacroix, Ludovic ^a   Bidart, Jean Michel ^a   Baudin, Eric ^a   Schlumberger, Martin ^a   Caillou, Bernard ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; GALAPTIN; GALECTIN 3; TUMOR MARKER; CARCINOEMBRYONIC ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CALCITONIN BLOOD LEVEL; CELL ADHESION; CELL HYPERPLASIA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; ONCOGENE RET; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; THYROID MEDULLARY CARCINOMA; THYROID PARAFOLLICULAR CELL; THYROIDECTOMY; TUMOR GROWTH; CHEMISTRY; CHI SQUARE DISTRIBUTION; HYPERPLASIA; MEDULLARY CARCINOMA; METHODOLOGY; PATHOLOGY; PRECANCER; PRESCHOOL CHILD; THYROID GLAND; THYROID TUMOR;

ADOLESCENT; ADULT; CALCITONIN; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, MEDULLARY; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; GALECTIN 3; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; PRECANCEROUS CONDITIONS; SENSITIVITY AND SPECIFICITY; THYROID GLAND; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036885919     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2002.01673.x     Document Type: Article

References (27)

1. Barondes, S.H., Cooper, D.N.W., Gitt, M.A. & Leffler, H. (1994) Galectin: structure and function of a large family of animal lectins. Journal of Biological Chemistry, 269, 20807-20810.
2. Bartolazzi, A., Gasbarri, A., Papotti, M., Bussolati, G., Lucante, T., Khan, A., Inohara, H., Marandino, F., Orlandi, F., Nardi, F., Vecchione, A., Tecce, R., Larsson, O. & Thyroid Cancer Study Group (2001) Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet, 357, 1644-1650.
3. Bresalier, R.S., Yan, P.S., Byrd, J.C., Lotan, R. & Raz, A. (1997) Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the nervous system. Cancer, 80, 776-787.
4. Butler, M. & Khan, S. (1986) Immunoreactive calcitonin in amyloid fibrils of medullary carcinoma of the thyroid gland. An immunogold staining technique. Archives of Pathology and Laboratory Medicine, 110, 647-649.
5. Cvejic, D., Savin, S., Golubovic, S., Punovic, I., Tatic, S. & Havelka, M. (2000) Galectin-3 and carcinoembryonic antigen expression in medullary thyroid carcinoma: possible relation to tumor progression. Histopathology, 37, 530-535.
6. Fernandez, P.L., Merino, M.J., Gomez, M., Campo, E., Medina, T., Castronovo, V., Sanjuan, X., Cardesa, A., Liu, F.T. & Sobel, M.E. (1997) Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue. Journal of Pathology, 181, 80-86.
7. Gimm, O. (2001) Thyroid cancer. Cancer Letters, 163, 143-156.
8. Hermanek, P. & Sobin, L.H. (1992) TNM classification of malignant tumors. In: Thyroid Gland, 4th edn (eds P. Hermanek & L.H. Sobin), pp. 35-37. Berlin, Germany: Springer-Verlag.
9. Inohara, H., Akahani, S., Koths, K. & Raz, A. (1996) Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion. Cancer Research, 56, 4530-4534.
10. Inohara, H., Honjo, Y., Yoshii, T., Akahani, S., Yoshida, J., Hattori, K., Okamoto, S., Sawada, T., Raz, A. & Kubo, T. (1999) Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Cancer, 85, 2475-2484.
11. Inohara, H. & Raz, A. (1995) Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion. Cancer Research, 55, 3267-3271.
12. Irimura, T., Matsushita, Y., Sutton, R., Carralero, D., Ohannesian, D.W., Cleary, K.R., Ota, D.M., Nicolson, G.L. & Lotan, R. (1991) Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stages. Cancer Research, 51, 387-393.
13. Kakudo, K., Carney, J.A. & Sizemore, J.W. (1985) Medullary carcinoma of the thyroid. Biological behavior of the sporadic and familial neoplasm. Cancer, 55, 2818-2821.
14. Kawachi, K., Matsushita, Y., Yonezawa, S., Nakano, S., Shirao, K., Natsugoe, S., Sueyoshi, K., Aikou, T. & Sato, E. (2000) Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation. Human Pathology, 31, 428-433.
15. Lloyd, R.V. (2001) Distinguishing benign from malignant thyroid lesions: galectin-3 as the latest candidate. Endocrine Pathology, 12, 255-257.
16. Lloyd, R.V., Sisson, J.C. & Marangos, P.J. (1983) Calcitonin, carcinoembryonic antigen and neuron-specific enolase in medullary thyroid carcinoma. Cancer, 21, 2234-2239.
17. Lotan, R. (1992) β-galactoside-binding vertebrate lectins: synthesis, molecular function. In: Glycoconjugates: Composition and Function (eds H. Allen & E. Kisailus), pp. 635-671. New York: Marcel Dekker, Inc.
18. Moutsatsos, I.K., Wade, M., Schindler, M. & Wang, J.L. (1987) Endogenous leptons from cultured cells: nuclear localization of carbohydrate-binding protein 35 in proliferating 3T3 fibroblasts. Proceedings of the National Academy of Sciences, 84, 6452-6456.
19. Nascimento, M.C., Bisi, H., Alves, V.A., Longatto-Filho, A., Kanamura, C.T. & Medeiros-Neto, G. (2001) Differential reactivity for galectin-3 in Hurthle cell adenomas and carcinomas. Endocrine Pathology, 12, 275-279.
20. Ohannesian, D.W., Lotan, D., Thomas, P., Jessup, J.M., Fukuda, M., Gabius, H.J. & Lotan, R. (1995) Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells. Cancer Research, 55, 2191-2199.
21. Raz, A., Zhu, D., Hogan, V., Shah, N., Raz, T., Karkash, R., Pazerini, G. & Carmi, P. (1990) Evidence for the role of 34 kDa galactoside-binding lectin in trasformation and metastasis. International Journal of Cancer, 6, 871-877.
22. Saad, M.F., Ordonez, N.G., Rashid, R.K., Guido, J.J., Hill, C.S. Jr, Hickey, R.C. & Samaan, N.A. (1984) Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients. Medicine, 63, 319-342.
23. Saggiorato, E., Cappia, S., De Giuli, P., Mussa, A., Pancani, G., Caraci, P, Angeli, A. & Orlandi, F. (2001) Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 86, 5152-5158.
24. Sanjuan, X., Fernandez, P.L., Castells, A., Castronovo, V., Van den Brule, F., Liu, F.T., Cardesa, A. & Campo, E. (1997) Differential expression of galectin-3 and galectin-1 in colorectal cancer progression. Gastroenterology, 113, 1906-1915.
25. Santesanio, G., Iafrate, E., Partenzi, A., Mauriello, A., Autelitano, F. & Spagnoli, L.G. (1997) A critical reassessment of the concept of C-cell hyperplasia of the thyroid: a quantitative immunohistochemical study. Applied Immunohistochemistry, 5, 160-172.
26. Schroder, S., Bocker, W., Baisch, H., Burk, C.G., Arps, H., Meiners, I., Kastendieck, H., Heitz, P.U. & Kloppel, G. (1988) Prognostic factors in medullary thyroid carcinomas. Survival in relation to age, sex, stage, histology, immunocytochemistry, and DNA content. Cancer, 61, 806-816.
27. Xu, X.C., el-Naggar, A.K. & Lotan, R. (1995) Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. American Journal of Pathology, 14, 815-822.